| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/10/2007 | EP1740185A1 Benzodiazepines for treating or preventing rsv infection |
| 01/10/2007 | EP1740184A1 Combinations of signal transduction inhibitors |
| 01/10/2007 | EP1740183A1 Novel use for pde5 inhibitors |
| 01/10/2007 | EP1740182A2 Use of 5,10-methylene tetrahydrofolate for the treatment of cancer |
| 01/10/2007 | EP1740181A1 New pharmaceutical compositions for the treatment of sexual disorders ii |
| 01/10/2007 | EP1740180A1 Use of flibanserin in the treatment of premenstrual and other female sexual disorders |
| 01/10/2007 | EP1740179A1 Method of treating neuropathic pain using a crth2 receptor antagonist |
| 01/10/2007 | EP1740178A2 Methods and compositions for the treatment, prevention or management of diysfunctional sleep and dysfunctional sleep associated with disease |
| 01/10/2007 | EP1740177A2 Muscarinic acetylcholine receptor antagonists |
| 01/10/2007 | EP1740176A2 Pharmaceutical compositions comprising anti-inflammatory quinazolinecarboxamide derivatives |
| 01/10/2007 | EP1740175A1 Use of a cgrp-antagonist combined with a serotonin-reuptake inhibitor in order to treat migraines |
| 01/10/2007 | EP1740174A1 Derivatives of aryl(or heteroaryl) azolylcarbinols for the treatment of enuresis |
| 01/10/2007 | EP1740173A1 Azabicyclo-octane inhibitors of iap |
| 01/10/2007 | EP1740172A2 Acetylcholinesterase inhibitors and n-methyl-d-aspartate antagonists useful in the treatment of cognitive disorders |
| 01/10/2007 | EP1740171A1 Indol-1-yl-acetic acid derivatives |
| 01/10/2007 | EP1740170A2 Combination therapy with azd2171 and platinum anti-tumour agent |
| 01/10/2007 | EP1740169A1 Immunomoduating agent, anti-cancer agent and health food containing monoacetyldiacylglycerol derivatives |
| 01/10/2007 | EP1740168A2 Antiprostaglandins for the treatment of ocular pathologies |
| 01/10/2007 | EP1740167A2 Treatment of type 1 diabetes with inhibitors of macrophage migration inhibitory factor |
| 01/10/2007 | EP1740166A2 Therapeutic antimicrobial compositions and methods |
| 01/10/2007 | EP1740165A2 Therapeutic agents, methods, and treatments |
| 01/10/2007 | EP1740164A1 Statins for the treatment of ocular hypertension and glaucoma |
| 01/10/2007 | EP1740163A2 Multi-phase contraceptive preparation based on a natural estrogen |
| 01/10/2007 | EP1740162A1 Topical methadone compositions and methods for using the same |
| 01/10/2007 | EP1740161A2 Transdermal system secured against misuse |
| 01/10/2007 | EP1740159A1 Pharmanutrient composition(s) and system(s) for individualized, responsive dosing regimens |
| 01/10/2007 | EP1740157A1 Anti-excitotoxic sustained release intraocular implants and related methods |
| 01/10/2007 | EP1740156A1 Method for the production of an abuse-proof, solid form of administration |
| 01/10/2007 | EP1740155A1 Polycylic thiazoles as potassium ion channel modulators |
| 01/10/2007 | EP1740153A1 Biodegradable ocular implants with long-term release characteristics |
| 01/10/2007 | EP1740149A1 Composition comprising a monomer compound exhibiting an optical property, method making use of said composition, a monomer compound and a polymer containing said monomer compound and the use thereof |
| 01/10/2007 | EP1740120A2 Naltrexone long acting formulations and methods of use |
| 01/10/2007 | EP1740094A2 Pyridyl-substituted porphyrin compounds and methods of use thereof |
| 01/10/2007 | EP1740047A2 Compositions and methods for preventing and treating skin and hair conditions |
| 01/10/2007 | EP1694629A4 Higher fullerenes useful as radical scavengers |
| 01/10/2007 | EP1689757A4 Heterocyclic boronic acid compounds |
| 01/10/2007 | EP1680425B1 6- [(substituted)phenyl] triazolopyrimidines as anticancer agents |
| 01/10/2007 | EP1663991B1 Selective synthesis of cf3-substituted pyrimidines |
| 01/10/2007 | EP1656379B1 4-cycloalkylaminopyrazolo pyrimidine nmda/nr2b antagonists |
| 01/10/2007 | EP1620105B1 (6-(phenoxy)-pyrido¬3,4-d|pyrimidin-2-yl)-amine derivatives as p38 kinase inhibitors for the treatment of inflammatory conditions such as rheumatoid arthritis |
| 01/10/2007 | EP1572167A4 Transdermal buprenorphine dosage regimen for analgesia |
| 01/10/2007 | EP1560806B1 4-alkyl/4-alkenyl/4-alkynyl methyl/-1-arylcyclohexylamine derivatives |
| 01/10/2007 | EP1560581B1 Oromucosal formulation and process for preparing the same |
| 01/10/2007 | EP1521583B1 7,8,9,10-tetrahydro-6h-azepino, 6,7,8,9-tetrahydro-pyrido and 2,3-dihydro-2h-pyrrolo (2,1-b)-quinazolinone derivatives |
| 01/10/2007 | EP1507524B1 Topical use of diuretics for treating swellings |
| 01/10/2007 | EP1453505A4 Use of pramipexole to treat amyotrophic lateral sclerosis |
| 01/10/2007 | EP1443927B1 Carboline derivatives as inhibitors of ikb in the treatment of multiple myeloma |
| 01/10/2007 | EP1418915B1 Neuroprotective drug |
| 01/10/2007 | EP1416920B1 Multiplex drug delivery system suitable for oral administration |
| 01/10/2007 | EP1416885B1 Devices for delivery of therapeutic agents with variable release profile |
| 01/10/2007 | EP1414440B1 N-phenylpyrrole guanidine derivatives as melanocortin receptor ligands |
| 01/10/2007 | EP1406606B1 Carbamate compounds for use in preventing or treating neuropathic pain and cluster and migraine headache-associated pain |
| 01/10/2007 | EP1392320B1 17-METHYLENE-ANDROSTAN-3a-OL ANALOGS AS CRH INHIBITORS |
| 01/10/2007 | EP1355916B1 Nucleoside derivatives as inhibitors of rna-dependent rna viral polymerase |
| 01/10/2007 | EP1355632B1 Amlodipine free base |
| 01/10/2007 | EP1353905B1 Piperidine/piperazine-type inhibitors of p38 kinase |
| 01/10/2007 | EP1345945B1 Streptogramin derivatives, preparation thereof and compositions containing same |
| 01/10/2007 | EP1335687B1 Method for restoring a damaged or degenerated intervertebral disc |
| 01/10/2007 | EP1305051A4 Targeted delivery of cytotoxic drugs a) to activated lymphocytes in patients with transplanted organs, b) as radiosensitizers to cancer cells in patients undergoing radiation therapy, and c) in vitamin-binding proteins as drug carriers in the diagnosis and treatment of cancer |
| 01/10/2007 | EP1244447B1 Novel methods and compositions involving opioids and antagonists thereof |
| 01/10/2007 | EP1218011B1 Gallium complexes of 3-hydroxy-4-pyrones to treat infection by intracellular prokaryotes, dna viruses and retroviruses |
| 01/10/2007 | EP1200073B1 SELECTIVE iGluR 5? RECEPTOR ANTAGONISTS FOR THE TREATMENT OF MIGRAINE |
| 01/10/2007 | EP1194147B1 Arylthiazolidinedione and aryloxazolidinedione derivatives |
| 01/10/2007 | EP1176984B1 Medicament vehicle for the controlled administration of an active agent, produced from lipid matrix-medicament conjugates |
| 01/10/2007 | EP1121114B1 Use of gaba analogs for the manufacture of a medicament for the treatment of mania and bipolar disorders |
| 01/10/2007 | EP1109803B1 Substituted imidazoles having cytokine inhibitory activity |
| 01/10/2007 | EP1087946B1 Aryl alkanoylpyridazines |
| 01/10/2007 | EP1078060B1 Antibodies to dendritic cells and human dendritic cell populations and uses thereof |
| 01/10/2007 | EP1054672B1 Morphine sulphate microgranules, method for making same and pharmaceutical preparations |
| 01/10/2007 | EP1035856B1 Isolated dna encoding human h3 histamine receptor |
| 01/10/2007 | EP0920300B2 Vegetable oil compositions |
| 01/10/2007 | EP0915705B1 Ionic polymers as anti-infective agents |
| 01/10/2007 | EP0914440B1 Nucleic acid vaccination for parvoviral infections |
| 01/10/2007 | EP0866709B1 1,2,4-benzotriazine oxides formulations |
| 01/10/2007 | EP0821585B1 Use of alpha 1l-agonists in the treatment of urinary incontinence |
| 01/10/2007 | EP0794793B1 Composition for prevention and treatment of hiv-1 infection comprising at least two different hiv-1 reverse transcriptase inhibitors |
| 01/10/2007 | EP0782580B1 Parallel selex |
| 01/10/2007 | CN1894410A DNA-sequence and recombinant production of group 4 major allergens from cereals |
| 01/10/2007 | CN1894344A Compounds for dual photodiagnosis and therapy |
| 01/10/2007 | CN1894280A Glycosylation-deficient hepatocyte growth factor |
| 01/10/2007 | CN1894278A Akt activity specifically inhibiting polypeptide |
| 01/10/2007 | CN1894276A HCV NS3-NS4A protease resistance mutants |
| 01/10/2007 | CN1894274A Macrocyclic inhibitors of hepatitis C virus NS3-serine protease |
| 01/10/2007 | CN1894271A Glycosylated steroid derivatives with anti-migratory activity |
| 01/10/2007 | CN1894270A Stabilized azithromycin composition |
| 01/10/2007 | CN1894260A Pyrido- and pyrimidopyrimidine derivatives as anti-proliferative agents |
| 01/10/2007 | CN1894259A Rifamycin analogs and uses thereof |
| 01/10/2007 | CN1894258A Compositions useful as inhibitors of protein kinases |
| 01/10/2007 | CN1894256A Method for preparing spironolactone compounds |
| 01/10/2007 | CN1894251A Crystalline forms of (6R)-l-erythro-tetrahydrobiopterin dihydrochloride |
| 01/10/2007 | CN1894250A Substituted 8-heteroaryl xanthines |
| 01/10/2007 | CN1894248A Synthesis of a polymorph of 4-amino-5-chlor0-2-methoxy-n-(1-azabicyclo[3.3.1]non-4-yl)benzamide hydrochloride hydrate |
| 01/10/2007 | CN1894246A Novel crystalline forms of 2,3-dimethyl-8-(2,6-dimethylbenzylamino)-n-hydroxyethyl-imidazo[1,2-a]pyridine-6-carboxamide mesylate salt |
| 01/10/2007 | CN1894245A Pyrido[2,3-d]pyrimidine-2,4-diamines as PDE2 inhibitors |
| 01/10/2007 | CN1894244A Aryl ether substituted imidazoquinolines |
| 01/10/2007 | CN1894243A 4-(pyrazol-3-ylamino) pyrimidine derivatives for use in the treatment of cancer |
| 01/10/2007 | CN1894241A '1,2,4' oxadiazoles as modulators of metabotropic glutamate receptor-5 |
| 01/10/2007 | CN1894240A 阿片受体拮抗剂 Opioid receptor antagonist |
| 01/10/2007 | CN1894239A Piperidine-amino-benzimidazole derivatives as inhibitors of respiratory syncytial virus replication |
| 01/10/2007 | CN1894238A Diamine derivatives |